Vimarsana
Biggest News Aggregation in the World

Taro Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Taro Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Taro Pharma Today - Breaking & Trending Today

Weak Q4 may be rare bitter pill for Sun Pharma - Vimarsana News

Weak Q4 may be rare bitter pill for Sun Pharma

Sun Pharmaceutical Industries reported a 34 per cent year-on-year (Y-o-Y) jump in net profit to Rs 2,654.6 crore in Q4FY24.

Source: rediff.com
Sanjiv Bhasin | Sanjiv Bhasin stocks: We are a little cautious on Bhel; trimmed position in Zomato and PB Fintech: Sanjiv Bhasin - Vimarsana News

Sanjiv Bhasin | Sanjiv Bhasin stocks: We are a little cautious on Bhel; trimmed position in Zomato and PB Fintech: Sanjiv Bhasin

Sanjiv Bhasin advises caution on Bhel stock due to parabolic rise, suggests focusing on rail stocks instead for investment opportunities. Bhasin says we would say be a little cautious, wait out, hear the commentary and let some corrections come in because now you are chasing a parabolic rise which may not last for long.

Sun Pharma Acquisition: Remaining Stake in Taro for $348 Million | India Business News - Vimarsana News

Sun Pharma Acquisition: Remaining Stake in Taro for $348 Million | India Business News

India Business News: Sun Pharma announces the acquisition of the remaining stake in its subsidiary Taro for $348 million. Find out more about this strategic move and its impact on the pharmaceutical industry.

Sun Pharma and Taro announce merger agreement - Vimarsana News

Sun Pharma and Taro announce merger agreement

Sun Pharma’s efforts to mop up the remaining shares in Israel’s Taro Pharma have reached the final stage with the two companies

Source: wn.com
Sun Pharma hits 52-week high on acquiring Israeli company - Vimarsana News

Sun Pharma hits 52-week high on acquiring Israeli company

Libra Merger Ltd is Sun’s second buy in Israel after Taro Pharma, a high-profile acquisition for the Indian drug company